Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1651
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $17.3M | ﹤0.01% |
784,930
+61,805
| +9% | +$1.24M |
|
1652
Dynatrace
DT
$14.3B
| $17.3M | ﹤0.01% |
683,161
+324,561
| +91% | +$7.13M |
|
1653
AtriCure
ATRC
$2.22B
| $17.2M | ﹤0.01% |
530,241
+19,405
| +4% | +$552K |
|
1654
James River Group Holdings
JRVR
$199M
| $17.2M | ﹤0.01% |
417,586
+13,490
| +3% | +$530K |
|
1655
Enterprise Financial Services Corp
EFSC
$2.41B
| $17.2M | ﹤0.01% |
356,642
+18,416
| +5% | +$818K |
|
1656
Fate Therapeutics
FATE
$317M
| $17.2M | ﹤0.01% |
876,835
+64,302
| +8% | +$1.02M |
|
|
MDP
1657
DELISTED
Meredith Corporation
MDP
| $17.1M | ﹤0.01% |
528,121
+16,507
| +3% | +$587K |
|
|
FBC
1658
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $17.1M | ﹤0.01% |
447,228
+83,911
| +23% | +$3.14M |
|
1659
Inogen
INGN
$154M
| $17M | ﹤0.01% |
248,913
+5,312
| +2% | +$333K |
|
|
FSCT
1660
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $17M | ﹤0.01% |
517,471
+16,157
| +3% | +$530K |
|
1661
STAAR Surgical
STAA
$1.27B
| $17M | ﹤0.01% |
482,471
+22,563
| +5% | +$744K |
|
1662
Supernus Pharmaceuticals
SUPN
$2.78B
| $17M | ﹤0.01% |
715,384
+20,299
| +3% | +$493K |
|
1663
ePlus
PLUS
$2.32B
| $16.9M | ﹤0.01% |
401,004
+36,022
| +10% | +$1.47M |
|
1664
Kforce
KFRC
$1.03B
| $16.9M | ﹤0.01% |
425,624
+235
| +0.1% | +$9.29K |
|
|
TPTX
1665
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $16.9M | ﹤0.01% |
271,255
+124,236
| +85% | +$5.91M |
|
1666
Appian
APPN
$2.49B
| $16.9M | ﹤0.01% |
442,183
+29,271
| +7% | +$1.26M |
|
1667
Granite Construction
GVA
$5.52B
| $16.9M | ﹤0.01% |
609,393
+10,838
| +2% | +$308K |
|
1668
Southside Bancshares
SBSI
$979M
| $16.9M | ﹤0.01% |
453,787
+7,470
| +2% | +$264K |
|
1669
CNA Financial
CNA
$13.7B
| $16.8M | ﹤0.01% |
375,629
-32,443
| -8% | -$1.46M |
|
1670
Addus HomeCare
ADUS
$2.2B
| $16.8M | ﹤0.01% |
172,748
+17,314
| +11% | +$1.52M |
|
1671
MACOM Technology Solutions
MTSI
$23.7B
| $16.8M | ﹤0.01% |
630,992
+23,482
| +4% | +$561K |
|
1672
Oxford Industries
OXM
$538M
| $16.7M | ﹤0.01% |
221,823
+7,353
| +3% | +$531K |
|
|
TWOU
1673
DELISTED
2U Inc
TWOU
| $16.7M | ﹤0.01% |
23,188
+1,152
| +5% | +$717K |
|
|
NP
1674
DELISTED
Neenah, Inc. Common Stock
NP
| $16.6M | ﹤0.01% |
235,651
+20,167
| +9% | +$1.37M |
|
1675
Strategy Inc
MSTR
$37.3B
| $16.6M | ﹤0.01% |
1,163,160
+34,720
| +3% | +$517K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.